(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session.

The three biggest winners today are Brainsway Ltd., Aurora Cannabis, and Catalyst Biosciences .

The three biggest losers today are Brilliant Acquisition Corporation, Axcella Health, and BOQI International Medical.

Winners today

1. Brainsway Ltd. (BWAY) – 13.95%

Brainsway Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, the Asia Pacific, Europe, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry. Brainsway Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel.

NASDAQ ended the session with Brainsway Ltd. rising 13.95% to $4.33 on Friday, after three sequential sessions in a row of gains. NASDAQ fell 1.56% to $13,708.33, after two successive sessions in a row of gains, on what was an all-around down trend trading session today.

Earnings Per Share

As for profitability, Brainsway Ltd. has a trailing twelve months EPS of $-0.9.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -27.36%.

Moving Average

Brainsway Ltd.’s worth is way above its 50-day moving average of $2.88 and way above its 200-day moving average of $2.16.

Yearly Top and Bottom Value

Brainsway Ltd.’s stock is valued at $4.33 at 17:32 EST, way below its 52-week low of $1.38.

More news about Brainsway Ltd..

2. Aurora Cannabis (ACB) – 12.69%

Aurora Cannabis Inc., together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada. It is also involved in the distribution of wholesale medical cannabis in the European Union (EU); distribution of wholesale medical cannabis in various international markets, including Australia, the Caribbean, South America, and Israel; supply of propagated vegetables and ornamental plants in North America; and distribution and sale of hemp-derived cannabidiol (CBD) products. In addition, the company cultivates and sells dried cannabis, cannabis oils, capsules, edible cannabis, cannabis extracts, and soft gels, which are ingested in various ways, including smoking, vaporizing, and consumption in the form of oil, capsules, edibles, and extracts; and provides dried flowers, vapes, dried milled strains, strain-specific extracts, strain specific cannabis oils, and concentrates. Further, it offers recreational cannabis products, such as flowers, vapes, ingestibles, concentrates, extracts, and CBD products; and patient counseling and outreach services. The company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard, as well as CBD brands, Reliva and KG7; and medical cannabis brands include MedReleaf, CanniMed, Aurora, Whistler Medical Marijuana Co, Pedanios, Bidiol, and CraftPlant. Aurora Cannabis Inc. is headquartered in Leduc, Canada.

NYSE ended the session with Aurora Cannabis rising 12.69% to $0.95 on Friday while NYSE fell 0.72% to $15,973.68.

Earnings Per Share

As for profitability, Aurora Cannabis has a trailing twelve months EPS of $-6.15.

Volume

Today’s last reported volume for Aurora Cannabis is 81069300 which is 433.42% above its average volume of 15197900.

More news about Aurora Cannabis.

3. Catalyst Biosciences (CBIO) – 8.52%

Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of liver fibrosis associated with a broad spectrum of chronic liver diseases in the United States and internationally. It develops Hydronidone, that has completed phase 1 clinical trial for the treatment of nonalcoholic steatohepatitis, a severe form of nonalcoholic fatty liver disease. The company was founded in 2002 and is headquartered in South San Francisco, California.

NASDAQ ended the session with Catalyst Biosciences jumping 8.52% to $0.56 on Friday, after three consecutive sessions in a row of gains. NASDAQ slid 1.56% to $13,708.33, after two successive sessions in a row of gains, on what was an all-around down trend trading session today.

Earnings Per Share

As for profitability, Catalyst Biosciences has a trailing twelve months EPS of $-1.63.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -113.14%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Catalyst Biosciences ‘s EBITDA is -4.59.

More news about Catalyst Biosciences .

4. Cardlytics (CDLX) – 7.27%

Cardlytics, Inc. operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing. The company was incorporated in 2008 and is headquartered in Atlanta, Georgia.

NASDAQ ended the session with Cardlytics rising 7.27% to $19.17 on Friday while NASDAQ slid 1.56% to $13,708.33.

Earnings Per Share

As for profitability, Cardlytics has a trailing twelve months EPS of $-12.22.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -95.45%.

More news about Cardlytics.

5. Canopy Growth (CGC) – 6.8%

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include dried cannabis flower, extracts and concentrates, beverages, gummies, and vapes. It offers its products under the Tweed, 7ACRES, 7ACRES Craft Collective, DOJA, Ace Valley, Quatreau, Deep Space, First + Free, Surity Pro, Spectrum Therapeutics, Vert, Tokyo Smoke, Twd, Martha Stewart CBD, DNA Genetics, BioSteel, Storz & Bickel, This Works, HiWay, Simple Stash, Whisl, and Truverra brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation was incorporated in 2009 and is headquartered in Smiths Falls, Canada.

NASDAQ ended the session with Canopy Growth jumping 6.8% to $1.34 on Friday while NASDAQ dropped 1.56% to $13,708.33.

Earnings Per Share

As for profitability, Canopy Growth has a trailing twelve months EPS of $-1.51.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -99.56%.

Previous days news about Canopy Growth

• : canopy growth stock continues slide after big runup. According to MarketWatch on Wednesday, 13 September, "In regular trading on Tuesday, Canopy Growth stock fell nearly 21% after big runups in recent sessions after the U.S. Drug Enforcement Agency said on Aug. 30 it would review the Schedule I classification of cannabis. ", "Even with the loss, Canopy Growth stock is still up about 67% in the past five days."

More news about Canopy Growth.

6. Lumen Technologies (LUMN) – 6.55%

Lumen Technologies, Inc., a facilities-based technology and communications company, provides various integrated products and services under the Lumen, Quantum Fiber, and CenturyLink brands to business and residential customers in the United States and internationally. The company operates in two segments, Business and Mass Markets. It offers compute and application services, such as edge cloud services, IT solutions, unified communication and collaboration solutions, colocation and data center services, content delivery services, and managed security services; and IP and data services, including VPN data network, Ethernet, internet protocol (IP), and voice over internet protocol. The company also provides fiber infrastructure services comprising high bandwidth optical wavelength networks; and unlit optical fiber and related professional services. In addition, it offers voice and other services, including private line services, a direct circuit or channel specifically dedicated for connecting two or more organizational sites; a portfolio of traditional time division multiplexing voice services; and synchronous optical network-based ethernet, legacy data hosting services, and conferencing services. The company was formerly known as CenturyLink, Inc. and changed its name to Lumen Technologies, Inc. in September 2020. The company was incorporated in 1968 and is headquartered in Monroe, Louisiana.

NYSE ended the session with Lumen Technologies jumping 6.55% to $1.55 on Friday while NYSE slid 0.72% to $15,973.68.

Earnings Per Share

As for profitability, Lumen Technologies has a trailing twelve months EPS of $-11.23.

Volume

Today’s last reported volume for Lumen Technologies is 13332100 which is 37.52% below its average volume of 21339400.

Sales Growth

Lumen Technologies’s sales growth is negative 18.2% for the ongoing quarter and negative 6.3% for the next.

Volatility

Lumen Technologies’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.48%, a negative 1.20%, and a positive 4.26%.

Lumen Technologies’s highest amplitude of average volatility was 2.91% (last week), 2.75% (last month), and 4.26% (last quarter).

Growth Estimates Quarters

The company’s growth estimates for the present quarter and the next is a negative 50% and a negative 88.4%, respectively.

More news about Lumen Technologies.

7. Golden Bull Limited (BTBT) – 6.48%

Bit Digital, Inc., together with its subsidiaries, engages in the bitcoin mining business. It is also involved in the treasury management activities; and digital asset staking and digital asset mining businesses, as well as ethereum staking activities. The company was formerly known as Golden Bull Limited and changed its name to Bit Digital, Inc. in September 2020. Bit Digital, Inc. was founded in 2015 and is headquartered in New York, New York.

NASDAQ ended the session with Golden Bull Limited rising 6.48% to $2.30 on Friday while NASDAQ dropped 1.56% to $13,708.33.

Earnings Per Share

As for profitability, Golden Bull Limited has a trailing twelve months EPS of $-1.17.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -66.65%.

Moving Average

Golden Bull Limited’s worth is way below its 50-day moving average of $3.30 and above its 200-day moving average of $2.15.

Sales Growth

Golden Bull Limited’s sales growth is 30% for the present quarter and 99.7% for the next.

Volume

Today’s last reported volume for Golden Bull Limited is 2847600 which is 43.28% below its average volume of 5021230.

More news about Golden Bull Limited.

8. Blink Charging Co. (BLNK) – 6.43%

Blink Charging Co., through its subsidiaries, owns, operates, manufactures, and provides electric vehicle (EV) charging equipment and networked EV charging services in the United States and internationally. The company offers residential and commercial EV charging equipment that enable EV drivers to recharge at various location types. It also provides Blink Network, a cloud-based system that operates, maintains, and manages various Blink charging stations and associated charging data, back-end operations, and payment processing, as well as offers property owners, managers, parking companies, and state and municipal entities with cloud-based services that enable the remote monitoring and management of EV charging stations; and EV drivers with station information, including station location, availability, and applicable fees. In addition, the company offers EV charging hardware, software services, and service plans. It has strategic partnerships across transit/destination locations, including airports, auto dealers, healthcare/medicals, hotels, mixed-use and municipal locations, multifamily residential and condos, parks and recreation areas, parking lots, religious institutions, restaurants, retailers, schools and universities, stadiums, supermarkets, transportation hubs, and workplace locations. The company offers its services through direct sales force and resellers, as well as sells residential Level 2 chargers through various internet channels. Blink Charging Co. was founded in 2009 and is headquartered in Miami Beach, Florida.

NASDAQ ended the session with Blink Charging Co. jumping 6.43% to $3.97 on Friday, following the last session’s upward trend. NASDAQ slid 1.56% to $13,708.33, after two sequential sessions in a row of gains, on what was an all-around down trend exchanging session today.

Earnings Per Share

As for profitability, Blink Charging Co. has a trailing twelve months EPS of $-2.4.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -40.8%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 185.9%, now sitting on 94.36M for the twelve trailing months.

More news about Blink Charging Co..

9. Boxlight Corporation (BOXL) – 5.21%

Boxlight Corporation develops, sells, and services interactive classroom technology products and solutions for the K-12 education market worldwide. The company provides interactive and non-interactive projectors and flat panel displays, interactive touch projectors, touchboards, and MimioTeach that could turn any whiteboard interactive; and accessory document cameras, teacher pads for remote control, and assessment systems under the Mimio and Clevertouch brands. It also offers MimioStudio Interactive Instructional software that enables the creation, editing, and presentation of interactive instructional lessons and activities; MimioMobile, a software accessory for MimioStudio; Oktopus Instructional and Whiteboarding software that enables the creation, editing, and presentation of interactive instructional lessons and activities; Notes+, a software accessory for use with Oktopus software; GameZones, a multi-student interactive gaming software; and MimioConnect, an online student engagement platform. In addition, the company provides Juno, a towering standard of sound quality that reinforces a teacher's voice; Mimio MyBot system that bridges the gap between learning about robotics in the classroom and the application of robotics; Robo3D printers; MyStemKits, which offers standards-driven lesson plans for grades K-12 math and science teachers; MimioView document camera; EzRoom, an integrated AV solution; Lyrik, an amplification solution; and Conductor School Communication System, an IP-based, campus-wide communication and control solution, as well as peripherals and accessories, such as mobile carts, installation accessories, and wall-mount accessories for interactive and standard projectors, and LED flat panels. Further, it offers classroom training, professional development, and educator certification services. The company was formerly known as Logical Choice Corporation. Boxlight Corporation was founded in 1985 and is headquartered in Duluth, Georgia.

NASDAQ ended the session with Boxlight Corporation rising 5.21% to $2.22 on Friday while NASDAQ fell 1.56% to $13,708.33.

Earnings Per Share

As for profitability, Boxlight Corporation has a trailing twelve months EPS of $-0.38.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -3.5%.

More news about Boxlight Corporation.

10. Nautilus (NLS) – 5.03%

Nautilus, Inc., a fitness solutions company, designs, develops, sources, and markets cardio and strength fitness products, and related accessories for consumer use in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company operates through two segments, Direct and Retail. It offers cardio products, exercise bikes, treadmills, ellipticals, home gyms, dumbbells, kettlebells, and barbells primarily under the Nautilus, Bowflex, and Schwinn brands, as well as digital fitness platform under the JRNY brand. In addition, it engages in licensing its brands and intellectual properties. The company offers its products directly to consumers through television advertising, social media, websites, and catalogs; and through a network of retail companies consisting of sporting goods stores, online-only retailers, electronics stores, furniture stores, and large-format and warehouse stores, as well as specialty retailers and independent bike dealers. Nautilus, Inc. was founded in 1986 and is headquartered in Vancouver, Washington.

NYSE ended the session with Nautilus rising 5.03% to $0.83 on Friday, after five consecutive sessions in a row of losses. NYSE fell 0.72% to $15,973.68, following the last session’s upward trend on what was a somewhat negative trend trading session today.

Earnings Per Share

As for profitability, Nautilus has a trailing twelve months EPS of $-1.51.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -63.74%.

More news about Nautilus.

Losers Today

1. Brilliant Acquisition Corporation (BRLIW) – -30%

NASDAQ ended the session with Brilliant Acquisition Corporation sliding 30% to $0.07 on Friday while NASDAQ dropped 1.56% to $13,708.33.

Yearly Top and Bottom Value

Brilliant Acquisition Corporation’s stock is valued at $0.07 at 17:32 EST, below its 52-week low of $0.07.

More news about Brilliant Acquisition Corporation.

2. Axcella Health (AXLA) – -15.13%

Axcella Health Inc. operates as a clinical stage biotechnology company in the United States. It treats complex diseases and enhances health using endogenous metabolic modulator compositions. The company's lead product candidates include AXA1665 for the treatment of overt hepatic encephalopathy; and AXA1125 for treating non-alcoholic steatohepatitis. It also develops AXA4010, a hematology product candidate; and AXA2678, a muscle product candidate. The company was formerly known as Newco LS16, Inc. and changed its name to Axcella Health Inc. in June 2016. Axcella Health Inc. was incorporated in 2008 and is based in Cambridge, Massachusetts.

NASDAQ ended the session with Axcella Health sliding 15.13% to $1.01 on Friday, following the last session’s downward trend. NASDAQ dropped 1.56% to $13,708.33, after two successive sessions in a row of gains, on what was an all-around negative trend exchanging session today.

Are medical stocks lagging axcella health (axla) this year?This means that Axcella Health Inc. is outperforming the sector as a whole this year., To break things down more, Axcella Health Inc. belongs to the Medical – Biomedical and Genetics industry, a group that includes 533 individual companies and currently sits at #94 in the Zacks Industry Rank.

Earnings Per Share

As for profitability, Axcella Health has a trailing twelve months EPS of $-0.86.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -1370.17%.

Yearly Top and Bottom Value

Axcella Health’s stock is valued at $1.01 at 17:32 EST, way under its 52-week high of $2.49 and way above its 52-week low of $0.10.

Growth Estimates Quarters

The company’s growth estimates for the current quarter and the next is 85.3% and 84.8%, respectively.

Volume

Today’s last reported volume for Axcella Health is 20708400 which is 6.08% above its average volume of 19520000.

More news about Axcella Health.

3. BOQI International Medical (BIMI) – -12.7%

BIMI International Medical Inc., together with its subsidiaries, engages in the retail and wholesale distribution of medical devices, and pharmaceutical and other healthcare products in the People's Republic of China. The company operates in four segments: Wholesale Pharmaceuticals, Wholesale Medical Devices, Medical Services, and Retail Pharmacies. It distributes Stryker spinal products, Olympus endoscopes, imported imaging products, and diagnostic imaging equipment to drug stores, private clinics, pharmaceutical dealers, and hospitals in the Southwest region of the People's Republic of China. The company also distributes varieties of products, including raw ingredients for pharmaceutical products, antibiotics, cardiovascular drugs, and anti-obesity medicines. In addition, it offers prescription and over-the-counter drugs, nutritional supplements, traditional Chinese medicines, personal and family care products, medical devices, and miscellaneous items under the Lijiantang Pharmacy brand name. Further, the company provides medical services in the hospitals, as well as IT research and development services. It sells its medicine and other healthcare products to customers through its directly owned stores. The company was formerly known as BOQI International Medical Inc. and changed its name to BIMI International Medical Inc. in June 2021. BIMI International Medical Inc. was incorporated in 2000 and is headquartered in New York, New York.

NASDAQ ended the session with BOQI International Medical sliding 12.7% to $1.65 on Friday, following the last session’s downward trend. NASDAQ fell 1.56% to $13,708.33, after two successive sessions in a row of gains, on what was an all-around down trend exchanging session today.

Earnings Per Share

As for profitability, BOQI International Medical has a trailing twelve months EPS of $-5.92.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -177.29%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 17.8%, now sitting on 12.31M for the twelve trailing months.

Volume

Today’s last reported volume for BOQI International Medical is 50159 which is 52.66% below its average volume of 105961.

More news about BOQI International Medical.

4. Brilliant Acquisition Corporation (BRLIR) – -12.64%

NASDAQ ended the session with Brilliant Acquisition Corporation dropping 12.64% to $0.17 on Friday while NASDAQ slid 1.56% to $13,708.33.

Yearly Top and Bottom Value

Brilliant Acquisition Corporation’s stock is valued at $0.17 at 17:32 EST, way under its 52-week low of $0.20.

More news about Brilliant Acquisition Corporation.

5. Creative Realities (CREX) – -9.09%

Creative Realities, Inc., together with its subsidiaries, provides digital marketing technology and solutions in the United States and internationally. It offers digital merchandising systems and omni-channel customer engagement systems; interactive digital shopping assistants; advisors and kiosks; and other interactive marketing technologies, such as mobile, social media, point-of-sale transactions, beaconing, and Web-based media that enables its customers to engage with their consumers. The company also provides system hardware; professional and implementation services; software design and development; and software licensing, deployment, and maintenance and support services, as well as media management and distribution software platforms and networks; device and product management; and customized software service layers, systems, experiences, workflows, and integrated solutions. The company sells its solutions to the automotive, apparel and accessories, banking, baby/children, beauty, CPG, department stores, digital out-of-home, electronics, fashion, fitness, foodservice/quick service restaurant, financial services, gaming, luxury, mass merchants, mobile operators, and pharmacy retail industries. Creative Realities, Inc. is headquartered in Louisville, Kentucky.

NASDAQ ended the session with Creative Realities sliding 9.09% to $1.50 on Friday while NASDAQ dropped 1.56% to $13,708.33.

Earnings Per Share

As for profitability, Creative Realities has a trailing twelve months EPS of $-0.11.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -17.15%.

Moving Average

Creative Realities’s value is way under its 50-day moving average of $2.70 and way under its 200-day moving average of $2.37.

Sales Growth

Creative Realities’s sales growth is 10% for the present quarter and 40.6% for the next.

Volume

Today’s last reported volume for Creative Realities is 92654 which is 44.41% above its average volume of 64158.

Growth Estimates Quarters

The company’s growth estimates for the current quarter is a negative 150% and positive 88.9% for the next.

More news about Creative Realities.

6. Super Micro Computer (SMCI) – -7.76%

Super Micro Computer, Inc., together with its subsidiaries, develops and manufactures high performance server and storage solutions based on modular and open architecture in the United States, Europe, Asia, and internationally. Its solutions range from complete server, storage systems, modular blade servers, blades, workstations, full racks, networking devices, server sub-systems, server management software, and security software. The company provides application-optimized server solutions, rackmount and blade servers, storage, and subsystems and accessories; and server software management solutions, such as Server Management Suite, including Supermicro Server Manager, Supermicro Power Management software, Supermicro Update Manager, SuperCloud Composer, and SuperDoctor 5. In addition, it offers server subsystems and accessories comprising server boards, chassis, power supplies, and other accessories. Further, the company provides server and storage system integration, configuration, and software upgrade and update services; and technical documentation services, as well as identifies service requirements, creates and executes project plans, and conducts verification testing and technical documentation, and training services. Additionally, it offers help desk and on-site product support services for its server and storage systems; and customer support services, including ongoing maintenance and technical support for its products. The company provides its products to enterprise data centers, cloud computing, artificial intelligence, and 5G and edge computing markets. It sells its products through direct and indirect sales force, distributors, value-added resellers, system integrators, and original equipment manufacturers. The company was incorporated in 1993 and is headquartered in San Jose, California.

NASDAQ ended the session with Super Micro Computer sliding 7.76% to $249.75 on Friday while NASDAQ fell 1.56% to $13,708.33.

Earnings Per Share

As for profitability, Super Micro Computer has a trailing twelve months EPS of $11.43.

PE Ratio

Super Micro Computer has a trailing twelve months price to earnings ratio of 21.85. Meaning, the purchaser of the share is investing $21.85 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 37.67%.

Yearly Top and Bottom Value

Super Micro Computer’s stock is valued at $249.75 at 17:32 EST, way below its 52-week high of $357.00 and way above its 52-week low of $50.28.

More news about Super Micro Computer.

7. Coda Octopus Group (CODA) – -7.73%

Coda Octopus Group, Inc., together with its subsidiaries, develops, sells, and rentals underwater technologies and equipment for real time 3D imaging, mapping, defense, and survey applications in the United States of America and internationally. The company operates through two segments, Marine Engineering Business and Marine Technology Business. It sells technology solutions to the subsea and underwater markets. The company's solutions include geophysical systems, a geophysical data acquisition systems, processing, and analysis software that are used primarily by survey companies, offshore renewable companies, research institutions, and salvage companies; GNSS-aided navigation systems (attitude and positioning systems); Real time volumetric imaging sonar; and diver augmented vision display system. It offers CodaOctopus GeoSurvey products, such as hardware and software solutions for field acquisition of sidescan sonar and sub-bottom profiler; and CodaOctopus DA4G productivity suite of software that automates the tasks of analyzing, annotating, and mosaicing complex data sets. It markets its products under the CodaOctopus brand name. Coda Octopus Group, Inc. was founded in 1994 and is headquartered in Orlando, Florida.

NASDAQ ended the session with Coda Octopus Group dropping 7.73% to $5.85 on Friday while NASDAQ fell 1.56% to $13,708.33.

Earnings Per Share

As for profitability, Coda Octopus Group has a trailing twelve months EPS of $0.38.

PE Ratio

Coda Octopus Group has a trailing twelve months price to earnings ratio of 15.39. Meaning, the purchaser of the share is investing $15.39 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.96%.

Volume

Today’s last reported volume for Coda Octopus Group is 91061 which is 252.22% above its average volume of 25853.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Coda Octopus Group’s EBITDA is 2.52.

Revenue Growth

Year-on-year quarterly revenue growth declined by 22%, now sitting on 20.92M for the twelve trailing months.

Moving Average

Coda Octopus Group’s value is way under its 50-day moving average of $8.09 and way below its 200-day moving average of $7.84.

More news about Coda Octopus Group.

8. BeyondSpring (BYSI) – -6.38%

BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and for treatment of later-stage non-small cell lung cancer. It is also developing Plinabulin in combination with various immuno-oncology agents, including nivolumab, a PD-1 antibody for the treatment of non-small cell lung cancer; ipilimumab, a CTLA-4 antibody for the treatment of extensive-stage small cell lung cancer; and in combination with PD-1 or PD-L1 antibodies and radiation for the treatment of various cancers. In addition, the company engages in the development of three small molecule immune agents in preclinical stages; and a drug development platform. The company was founded in 2010 and is headquartered in New York, New York.

NASDAQ ended the session with BeyondSpring sliding 6.38% to $0.88 on Friday, following the last session’s downward trend. NASDAQ dropped 1.56% to $13,708.33, after two sequential sessions in a row of gains, on what was an all-around bearish trend trading session today.

Earnings Per Share

As for profitability, BeyondSpring has a trailing twelve months EPS of $-0.81.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -310.48%.

Yearly Top and Bottom Value

BeyondSpring’s stock is valued at $0.88 at 17:32 EST, way below its 52-week high of $3.45 and way higher than its 52-week low of $0.54.

Volume

Today’s last reported volume for BeyondSpring is 23731 which is 42.96% below its average volume of 41608.

More news about BeyondSpring.

9. Cardiff Oncology (CRDF) – -5.72%

Cardiff Oncology, Inc., a clinical-stage biotechnology company, develops novel therapies to treat various cancers in California. Its lead drug candidate is onvansertib, an oral selective Polo-like Kinase 1 Inhibitor to treatment a range of solid tumor cancers and hematologic malignancies, such as KRAS/NRAS-mutated metastatic colorectal and metastatic pancreatic cancer, as well as investigator-initiated trials in triple negative breast cancer and small cell lung cancer; and TROV-054 is a Phase 1b/2 for FOLFIRI and bevacizumab. It primarily serves pharmaceutical manufacturers. The company was formerly known as Trovagene, Inc. and changed its name to Cardiff Oncology, Inc. in May 2012. Cardiff Oncology, Inc. was incorporated in 1999 and is headquartered in San Diego, California.

NASDAQ ended the session with Cardiff Oncology sliding 5.72% to $1.73 on Friday, following the last session’s upward trend. NASDAQ slid 1.56% to $13,708.33, after two sequential sessions in a row of gains, on what was an all-around bearish trend trading session today.

Earnings Per Share

As for profitability, Cardiff Oncology has a trailing twelve months EPS of $-0.93.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -38.29%.

More news about Cardiff Oncology.

10. Cambium Networks Corporation (CMBM) – -5.6%

Cambium Networks Corporation, together with its subsidiaries, designs, develops, and manufactures wireless broadband and Wi-Fi networking infrastructure solutions. The company offers point-to-point fixed wireless backhaul and point-to-multipoint fixed wireless solutions; and enterprise solutions comprising cnMatrix cloud-managed wireless-aware switching solution, Xirrus Wi-Fi solutions, and Wi-Fi 6 access points which support cnMaestro and Xirrus XMS management. It also offers cnMatrix Ethernet enterprise switching solutions; cnMaestro and cnMaestro X network management platform that provide users with an integrated, intelligent, and easy to use tool for end-to-end network management; cnHeat, a network planning subscription service that provides a heat map coverage model display of locations for FWB connectivity; LINKPlanner that allows users to visualize and analyze hypothetical network deployment scenarios to evaluate performance and reliability; and cnArcher, a smartphone app that accelerates installation and deployment of fixed wireless products by field technicians. The company's products are used by businesses, governments, and service providers to build, expand, and upgrade broadband networks. It serves public or private network operators; broadband internet service providers; mobile network operators; mid-market enterprises, such as education, hospitality, multi-dwelling units, and retail; state and local government; energy, mining, rail operator and utility industries; and military agencies in North America, Europe, the Middle East, Africa, the Caribbean and Latin America, and the Asia Pacific. The company was formerly known as Vector Cambium Holdings (Cayman), Ltd. and changed its name to Cambium Networks Corporation in 2018. The was founded in 2011 and is headquartered in Rolling Meadows, Illinois.

NASDAQ ended the session with Cambium Networks Corporation sliding 5.6% to $7.25 on Friday, after two successive sessions in a row of losses. NASDAQ slid 1.56% to $13,708.33, after two successive sessions in a row of gains, on what was an all-around down trend exchanging session today.

Earnings Per Share

As for profitability, Cambium Networks Corporation has a trailing twelve months EPS of $0.75.

PE Ratio

Cambium Networks Corporation has a trailing twelve months price to earnings ratio of 9.67. Meaning, the purchaser of the share is investing $9.67 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.49%.

Volume

Today’s last reported volume for Cambium Networks Corporation is 104350 which is 42.96% below its average volume of 182961.

Sales Growth

Cambium Networks Corporation’s sales growth is negative 13.5% for the ongoing quarter and negative 20.5% for the next.

Yearly Top and Bottom Value

Cambium Networks Corporation’s stock is valued at $7.25 at 17:32 EST, way under its 52-week high of $24.19 and higher than its 52-week low of $7.23.

Revenue Growth

Year-on-year quarterly revenue growth declined by 14.1%, now sitting on 302.65M for the twelve trailing months.

More news about Cambium Networks Corporation.

Stay up to date with our winners and losers daily report